ianthelliformisamine b tfa

Ianthelliformisamine B TFA, an antibiotic enhancer, is used to against resistant Gram-negative bacteria.

Neurokinin B TFA belongs to the tachykinin family.Neurokinin B binds to a series of GPCR, including neurokinin receptors 1 (NK1R), NK2R, and nk3r, to modulate their biological effects

Thioether-cyclized helix B peptide, CHBP (TFA), is the trifluoroacetic (TFA) salt of CHBP. This form enhances metabolic stability and exhibits renoprotective effects by promoting autophagy, achieved through the inhibition of mTOR C1 and activation of mTOR C2 [1].

Orexin B, human (TFA) is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2.

Dynorphin B (1-13), a 13 amino acid, is an extraordinarily potent opioid peptide.

Dynorphin B (1-13) TFA acts as an agonist on opioid κ-receptor .

Orexin B, rat, mouse (Rat orexin B) TFA, an endogenous agonist for orexin receptors, binds to and activates the closely related orphan G protein-coupled receptors OX1-R and OX2-R. This compound is instrumental in stimulating food intake, increasing energy expenditure, and regulating sleep-wake cycles [1] [2] [3].

Polymyxin B nonapeptide TFA is a useful organic compound for research related to life sciences and the catalog number is T64687.

Ianthelliformisamine A TFA, an antibiotic enhancer, is used to against resistant Gram-negative bacteria.

Orexin B, human (TFA), functions as a native agonist for the Orexin receptor, exhibiting dissociation constants (Kis) of 420 nM for OX1 and 36 nM for OX2, respectively.

Ianthelliformisamine C TFA, an antibiotic enhancer, is used to against resistant Gram-negative bacteria.

FibrinopeptideB,human is a 14-amino acid polypeptide released from the amino terminus of the fibrinogen segment.

[Ala11,D-Leu15]-Orexin B(human) TFA is a potent, selective agonist for the orexin-2 receptor (OX2), demonstrating 400-fold higher selectivity for OX2 (EC 50 =0.13 nM) compared to the orexin-1 receptor (OX1) with an EC 50 of 52 nM.

Cyclotraxin B TFA, a cyclic peptide, serves as a highly potent and selective non-competitive inhibitor of TrkB, effectively impeding BDNF-triggered TrkB activity without altering BDNF binding affinity, evidenced by an IC50 of 0.30 nM. It is capable of crossing the blood-brain barrier, demonstrating analgesic and anxiolytic-like behavioral effects [1] [2] [3].

Lactoferricin B (4-14), bovine (TFA), is a peptide derived from bovine lactoferrin, specifically consisting of residues 4-14. This compound exhibits broad-spectrum antimicrobial activity against various microorganisms[1].